Paving a Path to Relief of Irritable Bowel Syndrome and Chronic Idiopathic Constipation: Live Patient Simulations Demonstrating Innovations in Diagnosis and Treatment

Tuesday, October 9, 2018
5:30 am – 7:30 am
Philadelphia Marriott Downtown
1201 Market Street
Philadelphia, PA 19107
Room: Salon GLK
Faculty Co-Chairs
Lin Chang, MD
Professor of Medicine
Vice-Chief, Vatche and Tamar Manounkian Division of Digestive Diseases
Co-Director, G. Oppenheimer Center for Neurobiology of Stress and Resilience
David Geffen School of Medicine at University of California
Los Angeles, CA
Darren M. Brenner, MD
Associate Professor of Medicine and Surgery
Director, Northwestern Neuro-gastromotility and Functional Bowel Programs
Director, Motts Tonelli GI Physiology Laboratory
Northwestern University Feinberg School of Medicine
Chicago, IL
This event is neither sponsored by nor endorsed by ACG.
This activity is provided by Paradigm Medical Communications, LLC.
Target Audience
This activity has been designed to meet the educational needs of gastroenterology clinicians. It may also be of benefit to gynecologists, pharmacists, and other clinicians who are interested and actively engaged in the management of patients with IBS and CIC.
Statement of Need
Irritable bowel syndrome (IBS) and chronic idiopathic constipation (CIC) are among the most commonly seen gastrointestinal disorders worldwide, and the personal impact on patients is substantial. IBS-C and IBS-D comprise a considerable proportion of the overall IBS population. Over-testing patients to diagnose either of these IBS subtypes, or CIC, to exclude other diseases is a persistent problem that is inconsistent with evidence-based guidelines and contributes to patients’ suffering, frustration, and dissatisfaction with care. Post-diagnosis, optimal management is controversial, and outcomes are variable. In addition, opportunities to improve outcomes with effective patient communication strategies are often missed. Through a carefully balanced presentation, two national-level experts in IBS and CIC management will present the latest evidence, guidelines, and patient-clinician communications strategies at key decision points using interactive case-based simulations presenting physician-patient scenarios.
Learning Objectives
Upon proper completion of this activity, participants should be better able to:
  • Identify symptoms and pathophysiologic traits suggesting irritable bowel syndrome or chronic idiopathic constipation.
  • Select appropriate, individualized therapy for managing irritable bowel syndrome or chronic idiopathic constipation, based on current clinical data as well as patients’ disease characteristics, needs, and preferences.
  • Identify practical recommendations and resources for optimizing patient-clinician interactions and providing patient education and counseling for coping with irritable bowel syndrome subtypes or chronic idiopathic constipation and their treatment.
5:30 am – 6:00 am
Registration and Complimentary Buffet Breakfast
6:00 am – 7:30 am

Clinical Program
  • Introduction/Overview of IBS and CIC
  • Patient Simulations and Discussions
  • Q&A and Discussion

Physician Accreditation Statement
Paradigm Medical Communications, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physician Credit Designation Statement
Paradigm Medical Communications, LLC, designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PA Continuing Education
PAs may claim a maximum 1.5 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
Nurse Practitioner Continuing Education
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.
Disclosure of Commercial Support
This activity is supported by an educational grant from Allergan, Inc and Ironwood Pharmaceuticals, Inc.

Disclosure of Conflicts of Interest
In accordance with ACCME requirements on disclosure, information about relationships with commercial interests (if any) for anyone contributing to content development will be included in materials distributed at the time of the activity.
To register for this complimentary symposium, please click Continue below or call toll-free: (877) 252-5100, ext. 1.